Geode Capital Management LLC Has $8.93 Million Holdings in Enhabit, Inc. (NYSE:EHAB)

Geode Capital Management LLC grew its position in Enhabit, Inc. (NYSE:EHAB) by 0.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,142,798 shares of the company’s stock after purchasing an additional 5,340 shares during the quarter. Geode Capital Management LLC owned about 2.27% of Enhabit worth $8,927,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in EHAB. FMR LLC increased its position in Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares during the period. Franklin Resources Inc. grew its position in shares of Enhabit by 19.6% during the 3rd quarter. Franklin Resources Inc. now owns 32,382 shares of the company’s stock worth $256,000 after purchasing an additional 5,317 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Enhabit by 37.8% during the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock worth $2,411,000 after purchasing an additional 83,707 shares during the period. Empowered Funds LLC raised its position in shares of Enhabit by 5.0% in the fourth quarter. Empowered Funds LLC now owns 175,824 shares of the company’s stock valued at $1,373,000 after buying an additional 8,448 shares in the last quarter. Finally, Stoneridge Investment Partners LLC raised its position in shares of Enhabit by 22.6% in the fourth quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company’s stock valued at $98,000 after buying an additional 2,308 shares in the last quarter.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a “buy” rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Trading Up 3.2 %

Shares of Enhabit stock opened at $7.52 on Thursday. The firm’s 50-day moving average price is $8.38 and its two-hundred day moving average price is $7.99. The company has a market capitalization of $379.61 million, a price-to-earnings ratio of -3.24 and a beta of 1.60. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $10.70.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.